Literature DB >> 17445317

The seroepidemiology of varicella zoster virus among pregnant Bangladeshi and white British women in the London Borough of Tower Hamlets, UK.

Y S Talukder1, G Kafatos, A Pinot de Moira, J Aquilina, S P Parker, N S Crowcroft, D W G Brown, J Breuer.   

Abstract

We investigated the comparative seroepidemiology of varicella zoster virus (VZV) in pregnant women of two ethnic groups, white British and Bangladeshi, living in an inner city area of London, United Kingdom. Women aged 16-45 years were recruited from antenatal clinics of the Royal London Hospital in the Borough of Tower Hamlets. Complete data were obtained from 275 white British and 765 Bangladeshi women. VZV antibody prevalence was 93.1% (95% CI 89.4-95.8) and 86.0% (95% CI 83.3-88.4) respectively. Women who were born in Bangladesh and lived there at least until the age of 15 years had the lowest odds of being immune (OR 0.37, 95% CI 0.22-0.63). This implies they will have an increased risk of varicella during pregnancy. Women arriving in the United Kingdom in adulthood should be screened routinely during pregnancy and vaccination offered postpartum if they are susceptible.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17445317      PMCID: PMC2870708          DOI: 10.1017/S0950268807008497

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  32 in total

1.  COMPARISONS BETWEEN CHICKENPOX IN A TROPICAL AND A EUROPEAN COUNTRY.

Authors:  Z MARETIC; M P COORAY
Journal:  J Trop Med Hyg       Date:  1963-12

2.  Infectiousness of communicable diseases in the household (measles, chickenpox, and mumps).

Authors:  R E H SIMPSON
Journal:  Lancet       Date:  1952-09-20       Impact factor: 79.321

3.  Analysis of serological surveys using mixture models: application to a survey of parvovirus B19.

Authors:  N J Gay
Journal:  Stat Med       Date:  1996-07-30       Impact factor: 2.373

Review 4.  Varicella infections in pregnancy and the newborn. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection.

Authors:  D Nathwani; A Maclean; S Conway; D Carrington
Journal:  J Infect       Date:  1998-01       Impact factor: 6.072

5.  Racial differences in herpes zoster and age at onset of varicella.

Authors:  R H Dworkin
Journal:  J Infect Dis       Date:  1996-07       Impact factor: 5.226

6.  Varicella-zoster virus epidemiology--a changing scene?

Authors:  C K Fairley; E Miller
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

7.  Racial differences in the occurrence of herpes zoster.

Authors:  K Schmader; L K George; B M Burchett; C F Pieper; J D Hamilton
Journal:  J Infect Dis       Date:  1995-03       Impact factor: 5.226

8.  Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases.

Authors:  G Enders; E Miller; J Cradock-Watson; I Bolley; M Ridehalgh
Journal:  Lancet       Date:  1994-06-18       Impact factor: 79.321

Review 9.  Review of varicella zoster seroepidemiology in India and Southeast Asia.

Authors:  B W Lee
Journal:  Trop Med Int Health       Date:  1998-11       Impact factor: 2.622

10.  Outcome after maternal varicella infection in the first 20 weeks of pregnancy.

Authors:  A L Pastuszak; M Levy; B Schick; C Zuber; M Feldkamp; J Gladstone; F Bar-Levy; E Jackson; A Donnenfeld; W Meschino
Journal:  N Engl J Med       Date:  1994-03-31       Impact factor: 91.245

View more
  15 in total

Review 1.  The role of seroepidemiology in the comprehensive surveillance of vaccine-preventable diseases.

Authors:  Sarah E Wilson; Shelley L Deeks; Todd F Hatchette; Natasha S Crowcroft
Journal:  CMAJ       Date:  2011-11-14       Impact factor: 8.262

Review 2.  Epidemiology and factors influencing varicella infections in tropical countries including Sri Lanka.

Authors:  S W P Lakmini Daulagala; Faseeha Noordeen
Journal:  Virusdisease       Date:  2018-07-06

Review 3.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

4.  Risk factors for susceptibility to varicella in newly arrived adult migrants in Canada.

Authors:  C Greenaway; J F Boivin; S Cnossen; C Rossi; B Tapiero; K Schwartzman; S Olson; M Miller
Journal:  Epidemiol Infect       Date:  2013-11-01       Impact factor: 4.434

5.  Seroprevalence of varicella-zoster virus among pregnant women in two teaching hospitals, Tehran, Iran.

Authors:  Mahshid Talebi-Taher; Maryam Kashanian; Katayoon Khalili
Journal:  Iran J Microbiol       Date:  2014-02

6.  Seroprevalence of cytomegalovirus, Epstein Barr virus and varicella zoster virus among pregnant women in Bradford: a cohort study.

Authors:  Lucy Pembrey; Pauline Raynor; Paul Griffiths; Shelley Chaytor; John Wright; Andrew J Hall
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

7.  Burden of post-herpetic neuralgia in a sample of UK residents aged 50 years or older: findings from the Zoster Quality of Life (ZQOL) study.

Authors:  Mick Serpell; Adam Gater; Stuart Carroll; Linda Abetz-Webb; Azharul Mannan; Robert Johnson
Journal:  Health Qual Life Outcomes       Date:  2014-06-11       Impact factor: 3.186

8.  Exposure rate of VZV among women attending antenatal care clinic in Sri Lanka - a cross sectional study.

Authors:  Saluwadana Walawwe Pavithra Lakmini Daulagala; Faseeha Noordeen; Mohamed Mukthar Fathina Fara; Chathura Rathnayake; Kapila Gunawardana
Journal:  BMC Infect Dis       Date:  2017-09-16       Impact factor: 3.090

9.  Varicella Coinfection in Patients with Active Monkeypox in the Democratic Republic of the Congo.

Authors:  Nicole A Hoff; Douglas S Morier; Neville K Kisalu; Sara C Johnston; Reena H Doshi; Lisa E Hensley; Emile Okitolonda-Wemakoy; Jean Jacques Muyembe-Tamfum; James O Lloyd-Smith; Anne W Rimoin
Journal:  Ecohealth       Date:  2017-09-11       Impact factor: 4.464

10.  Validity of a reported history of chickenpox in targeting varicella vaccination at susceptible adolescents in England.

Authors:  Nigel Field; Gayatri Amirthalingam; Pauline Waight; Nick Andrews; Shamez N Ladhani; Albert Jan van Hoek; Peter A C Maple; Kevin E Brown; Elizabeth Miller
Journal:  Vaccine       Date:  2013-07-16       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.